Merus Market Capitalization from 2010 to 2024
| MRUS Stock | USD 45.39 0.10 0.22% |
Check Merus BV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merus BV's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.7 M, Interest Expense of 7.6 M or Selling General Administrative of 62.8 M, as well as many indicators such as Price To Sales Ratio of 30.68, Dividend Yield of 0.0 or PTB Ratio of 4.18. Merus financial statements analysis is a perfect complement when working with Merus BV Valuation or Volatility modules.
Merus | Market Capitalization |
Latest Merus BV's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Merus BV over the last few years. It is Merus BV's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merus BV's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 3.11 B | 10 Years Trend |
|
Market Cap |
| Timeline |
Merus Market Capitalization Regression Statistics
| Arithmetic Mean | 349,270,803 | |
| Geometric Mean | 259,492,479 | |
| Coefficient Of Variation | 88.37 | |
| Mean Deviation | 221,971,582 | |
| Median | 265,191,921 | |
| Standard Deviation | 308,657,241 | |
| Sample Variance | 95269.3T | |
| Range | 1.1B | |
| R-Value | 0.70 | |
| Mean Square Error | 52942.6T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | 48,014,764 | |
| Total Sum of Squares | 1333770.1T |
Merus Market Capitalization History
About Merus BV Financial Statements
Merus BV shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Merus BV investors may analyze each financial statement separately, they are all interrelated. The changes in Merus BV's assets and liabilities, for example, are also reflected in the revenues and expenses on on Merus BV's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands. Merus NV is traded on NASDAQ Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Merus Stock Analysis
When running Merus BV's price analysis, check to measure Merus BV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merus BV is operating at the current time. Most of Merus BV's value examination focuses on studying past and present price action to predict the probability of Merus BV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merus BV's price. Additionally, you may evaluate how the addition of Merus BV to your portfolios can decrease your overall portfolio volatility.